MATERIALS AND METHODS

Ohigonucleotides
). We also used a random-sequence control fragment whose sequence was 5' (HMT)-CTCGAACGCTATCCA.
Cell culture
Human fibroblasts (HIb) were isolated from neonatal foreskins by incubating at 4#{176}C in a 0.25% trypsin solution overnight in a humidified, 5% CO2 incubator. 
Monolayer culture experiments
Cells were brought to 80-90% confluency in FCM with 10% FCS in 12-well dishes. AS-HMT (10 jIM) or random sequence HMT oligomers were added to the culture medium in the dark. The cells were allowed to take up the oligomers for 24 h before irradiation. The cells were switched to serum-free media before UVA irradiation, because the presence of serum proteins in the media interferes with the detection of collagenase by Western blotting. The plates were irradiated at 5 or 10 i/cm2 UVA light 1)rovided by a PUVA lamp. The monolayer cultures were then incubated for a further 24 h in the dark. 
Dermal equivalent experiments
Normal human fibroblasts derived from neonatal human foreskin were used at passage 3-5 and dispersed into collagen lattices using standard procedures (22 to HMT was >90% from the supplier (Oligos, Etc., Inc.) (Fig. 1B) .
We compared the cross-linking efficiency of two AS-HMT oligomers with their target strands, contained within a portion of the collagenase mRNA transcript.
One AS-HMT oligomer tested contained a 5' TpA site (top oligomer in Fig. 2 ). The other AS-HMT oligomer tested did not contain a TpA site (bottom oligomer in Fig. 2 In lane 2, no cross-linking was evident when the target oligomer alone was irradiated.
In lane 3, the target ohgomer plus control random oligomer-HMT also did not cross-link after irradiation, indicating that HMT will not covalently cross-link an oligomer that does not specifically hybridize to its complementary target sequence. Significantly, the addition of the AS-HMT sequence in lane 4 gave an 80.1% cross-linking yield when irradiated with its target oligomer, as seen in the appearance of a higher molecular weight band.
We next evaluated the ability of the non-TpA oligomer to covalently cross-link to the target sense strand in the presence of UVA light. We were unable to observe any cross-linking in any of our experiments conducted at the same concentrations of oligomers used in Fig. 3A (data not shown). We therefore increased the concentration of both reactants to a 100-fold higher level than that used in 
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Sense Target: was only a small percentage of the total added, and was estimated by densitometric scanning of the ethidiumstained gel itnage to be only 1.4% of the reactant oligomers.
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We tested the two AS-HMT oligomers in a variety of assays to measure the inhibition of collagenase I, as described below, but observed no consistent results with the AS-HMT oligomer that did not contain the TpA site. Our results are consistent with the antisense ohigomer that targets the TpA site being much more efficient at cross-linking the sense strand target sequence.
Further negative experiments using the AS-HMT oligomer without the TpA site are not shown.
Collagenase AS-HMT was added to in vitro synthesized collagenase mRNA and translated by nuclease-treated rabbit reticulocyte to yield the 54 kDa primary protein translation product for collagenase I (the higher of four bands) in the SDS-PAGE in Fig. 4 . The other bands correspond to degradation products of the collagenase protein. Lanes 1-6 were control reactions as follows. In lanes 1 and 2, in vitro translation was done without any antisense ohigomers added to the sample, in the absence or presence of UVA light, respectively.
In lanes 3 through 6, a random Sequence-HMT oligomer (lanes 3, 4) or the collagenase antisense ohigomer without HMT (lanes 5, 6) (Fig. 5, compare lanes 1 and 2) . In the presence of AS- 
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HMT oligomer and UVA light at either 5 or 10 i/cm2, a marked decrease (approx. 65% inhibition) in collagenase expression was observed as compared to the cells treated with UVA light alone (Fig. 5, lanes 3 and 4, and lanes 5  and 6) . Although UVA light alone does increase collagenase I levels, the amount of collagenase I expression in the presence of AS-HMT oligomer and UVA light was also below the nonirradiated controls.
In contrast, fibroblasts incubated with 10 p.M control-HMT, and either not irradiated or irradiated with 5 i/cm2 UVA light, were not inhibited in their collagenase I levels (compare lane 8 to lane 9).
Dermal equivalents, created by the dispersion of primary human fibroblasts into collagen lattices, were also used as a test system for the evaluation of AS-HMT inhibition of collagenase I. Fibroblasts are known to secrete higher levels of collagenase I in the presence of a collagen substrate (24), and so we were also interested in determining if the inhibition of collagenase I by the AS-HMT was also efficient at these higher expression levels. Similar to the experiments in fibroblast monolayers, dermal equivalents were incubated in the presence of 10 p.M AS-HMT for 24 h before UVA irradiation and assayed for collagenase I 24 h after UVA exposure.
Even in the absence of UVA treatment, but after incubation with the AS-HMT oligomer, collagenase I levels were diminished (Fig. 6, compare lanes  1 and 2) . In the presence of AS-HMT oligomer and UVA light at 5 i/cm2, a marked decrease in collagenase expression was also observed as compared to the cells not treated with the AS-HMT oligomer (Fig. 6, compare lanes 3 and  4) . Untreated and AS-HMT-treated dermal equivalents displayed no significant differences in 35S-Met labeling of total trichloroacetic acid (TCA) -precipitated protein, indicating that antisense-HMT and UVA treatments are not generally toxic at the doses used, nor was there any decrease in collagenase I when dermal equivalents were that AS-HMT molecules at concentration effective in monolayer cell culture are able to penetrate the collagen matrix and be absorbed by the fibroblasts. A significant inhibition was observed with AS-HMT even in the absence of UVA light, which was not seen in our in vitro translation and monolayer cell culture experiments. Although we are presently uncertain why only this model system allowed the inhibition in the absence of UVA crosslinking, the higher levels of collagenase I mRNA in this system may contribute to the effect. The cross-linking effected by HMT and UVA light does result in a more efficient inhibition of collagenase I (Fig. 6, lanes 3 and 4) , and is sufficient to overcome the UVA-induced enhancement of collagenase expression also seen in monolayer cells. The use of UVA light allows spatial selectivity by crosslinking only a select population of AS-HMT ohigomers with their target sequences.
This physiologically irreversible link between the antisense oligomer and target sense mRNA would confer greater stability and specificity to the antisense oligomers because they could be applied to a localized area of skin and irradiated with activating UVA light.
A significant drawback of the use of UVA light to crosslinking AS-HMT to collagenase I mRNA is the increase in collagenase I expression levels in response to UVA treatment (23, 28). An attractive alternative to the use of UVA light is the possibility that the HMT moiety could be crosslinked using multiphoton excitation. 
